Ostial Appoints Mike Buck as Chief Executive Officer

July 1, 2024—Ostial Corporation, a medical technology company focused on aorto-ostial interventions, announced the appointment of Mike Buck as Chief Executive Officer. The company’s first product is the Flash aorto-ostial angioplasty system, a dual-balloon angioplasty catheter that is commercially available in the United States.

According to Ostial, Buck has more than 30 years of cardiovascular industry experience. He has held executive leadership positions at prominent companies, including Guidant, Abbott, and Cardinal Health.

Most recently, Buck served as Founder and Chief Executive Officer at Truvic Medical—acquired by Imperative Care Vascular in 2021—which he led from concept through commercialization of the company’s next-generation thrombectomy solutions.

“I am honored and excited to join Ostial as CEO,” stated Buck in the company’s press release. “Delivering solutions that enable physicians to confidently treat vascular disease, while ensuring successful outcomes is our top priority. The Flash system fulfills this commitment while serving as a platform for growth as we explore opportunities to bring additional innovative solutions to the market.”

Ostial is an Incept LLC portfolio company headquartered in Campbell, California. Fred Khosravi, who is cofounder and managing partner of Incept, serves as Chairman of the Board of Ostial.

“We are thrilled to welcome Mike to Ostial at such a pivotal point in our company’s growth trajectory,” commented Khosravi in Ostial’s press release. “Given Mike’s proven track record of consistently delivering outstanding results throughout his career, combined with his deep industry knowledge, extensive operational experience, and commercial leadership, we have the utmost confidence in his ability to lead and transform Ostial through the next phase of the company.”